FDA approves Rocket gene therapy for rare immune disorder, District of Columbia, Washington Beloud

@statnews.com · 2 hours

FDA approves Rocket gene therapy for rare immune disorder

FDA approves Rocket gene therapy for rare immune disorder

The FDA has approved Rocket Pharma's gene therapy, Kresladi, for the rare immune disorder severe leukocyte adhesion deficiency type 1 (LAD-1). The therapy, tested in nine patients with posit...

Read more Statnews.com